SIR-Sphere Y-90

Closed Special Notice Posted

Solicitation number
SphereY90
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Gaithersburg, Maryland 20899, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Health Agency Contracting Activity (DHACA), Northeast Healthcare Contracting Division - Northeast (NCD-NE), has issued a Special Notice of Intent to award a Firm Fixed Price Blanket Purchase Agreement (BPA) to Sirtex Medical, Inc. The notice specifically relates to the procurement of SIR-Sphere Y-90 radioactive resin microspheres, a medical technology used for treating unresectable metastatic liver tumors. The procurement will be conducted on behalf of the Nuclear Medicine Department at Walter Reed National Military Medical Center (WRNMMC). The award will be made under FAR 13.5 Simplified Procedures for Certain Commercial Items, specifically utilizing the sole source authority outlined in FAR 13.501(a)(1)(ii). The opportunity is categorized under NAICS code 334517 with a small business size standard of 1,200 employees.

The primary objective of this Special Notice is to procure SIR-Spheres Y-90 resin microspheres, which are indicated for treating unresectable metastatic liver tumors from primary colorectal cancer, to be used in conjunction with intra-hepatic artery chemotherapy. The notice was posted on May 28, 2025, with a due date of June 9, 2025. Importantly, this is not a competitive solicitation, and the government will not honor or acknowledge requests for solicitation copies. The intended contractor, Sirtex Medical, Inc., is located in Woburn, Massachusetts, and will be awarded a Blanket Purchase Agreement for these specialized medical devices. The procurement falls under the Product Service Code (PSC) 6515 for medical and surgical instruments, equipment, and supplies. Contractors should note that this is a sole-source procurement, meaning no competitive bidding will occur, and the award is specifically targeted to Sirtex Medical, Inc.

Notice text

Notice of Intent for Peripheral Intervention technology identified as SIR-Sphere Y-90, which is a for the treatment of unresectable metastatic liver tumors.

The Defense Health Agency Contracting Activity (DHACA), Northeast Healthcare Contracting Division – Northeast (NCD-NE), on behalf of Nuclear Medicine Department at Walter Reed National Military Medical Center (WRNMMC), intends to award a Firm Fixed Price Blanket Purchase Agreement (BPA) with Sirtex Medical, Inc., (Cage: 45EE6), 300 Unicorn Park Drive, Woburn, MA 01801-3363.

The anticipated award will be made under the statutory authority permitting FAR 13.5, Simplified Procedures for Certain Commercial Items pursuant to FAR 13.501(a)(1)(ii), sole source (including brand name) under the authority of the simplified procedures for certain commercial items.  The Blanket Purchase Agreement is intended to procure Radioactive SIR-Spheres Y-90 resin microspheres are used for therapeutic imaging in Nuclear Medicine. SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine).

The NAICS code for this requirement is 334517 with a Small Business Size Standard: 1,200 Employees.  This notice of intent is NOT a request for competitive quotations. Requests for copies of a solicitation in response to this notice will not be honored or acknowledged.

 

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC– radiopharmaceuticals Bethesda, Maryland 20892, United States · NAICS 325412 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity